Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
SLE
In what clinical situations do you consider azathioprine for treatment of inflammatory arthritis?
Related Questions
When trying to increase infliximab for active disease (inflammatory arthritis or sarcoidosis), do you prefer to increase dosage or reduce frequency between doses?
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you approach diagnosis in a patient with inflammatory joint symptoms and isolated bilateral CMC joint erosions on x-ray imaging?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
